{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:54:09Z","timestamp":1769118849454,"version":"3.49.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0121620","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T18:31:42Z","timestamp":1427135502000},"page":"e0121620","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE)"],"prefix":"10.1371","volume":"10","author":[{"given":"Michal","family":"Droppa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Tschernow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin A. L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elli","family":"Tavlaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Karathanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Stimpfle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Schaeffeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tolios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta M.","family":"Siller-Matula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"W Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"PA Gurbel","year":"2003","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"I M\u00fcller","year":"2003","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"VL Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"US Tantry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"MJ Price","year":"2011","journal-title":"JAMA J Am Med Assoc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"J-P Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study","volume":"59","author":"D Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2007.02812.x","article-title":"The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score","volume":"6","author":"T Geisler","year":"2008","journal-title":"J Thromb Haemost JTH"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2012.04639.x","article-title":"Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study","volume":"10","author":"JM Siller-Matula","year":"2012","journal-title":"J Thromb Haemost JTH"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000160869.75810.98","article-title":"Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention","volume":"111","author":"W Hochholzer","year":"2005","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"T Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2013.03.036","article-title":"Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity","volume":"61","author":"S Spiliopoulos","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"PA Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"PA Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1160\/TH07-07-0478","article-title":"Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment","volume":"99","author":"D Sibbing","year":"2008","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"K Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0735-1097(95)00433-5","article-title":"Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting","volume":"27","author":"FJ Neumann","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00019501-199703000-00001","article-title":"Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis","volume":"8","author":"M Gawaz","year":"1997","journal-title":"Coron Artery Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.321.7253.73","article-title":"Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials","volume":"321","author":"HC Bucher","year":"2000","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjmed.2008.07.027","article-title":"The impact of revascularization on mortality in patients with nonacute coronary artery disease","volume":"122","author":"A Jeremias","year":"2009","journal-title":"Am J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jacc.2005.01.058","article-title":"Stent thrombosis is associated with an impaired response to antiplatelet therapy","volume":"45","author":"P Wenaweser","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1538-7836.2005.01751.x","article-title":"High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome","volume":"4","author":"T Cuisset","year":"2006","journal-title":"J Thromb Haemost JTH"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"J-S Hulot","year":"2006","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1503\/cmaj.060664","article-title":"Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel","volume":"174","author":"J-W Suh","year":"2006","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc06-1625","article-title":"Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation","volume":"30","author":"T Geisler","year":"2007","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00392-010-0179-x","article-title":"Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions","volume":"99","author":"T Geisler","year":"2010","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2010020220","article-title":"Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention","volume":"22","author":"P Htun","year":"2011","journal-title":"J Am Soc Nephrol JASN"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacc.2010.09.032","article-title":"Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel","volume":"57","author":"O Morel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.amjcard.2011.06.060","article-title":"Comparison of platelet reactivity and clopidogrel response in patients \u2264 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome","volume":"108","author":"T Cuisset","year":"2011","journal-title":"Am J Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/eurheartj\/ehr407","article-title":"High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study","volume":"33","author":"J Silvain","year":"2012","journal-title":"Eur Heart J"},{"key":"ref32","first-page":"169","article-title":"Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?","volume":"16","author":"DJ Angiolillo","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.amjcard.2009.07.015","article-title":"Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention","volume":"104","author":"N Bonello-Palot","year":"2009","journal-title":"Am J Cardiol"},{"key":"ref34","first-page":"8","article-title":"Effects of obesity on the cytochrome P450 enzyme system","volume":"37","author":"M Kotlyar","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.atherosclerosis.2007.04.048","article-title":"Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy","volume":"195","author":"R Marcucci","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.jacc.2010.02.005","article-title":"Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry","volume":"55","author":"ED Peterson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/eurheartj\/ehr034","article-title":"EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention","volume":"32","author":"M De Mulder","year":"2011","journal-title":"Eur Heart J"},{"key":"ref38","first-page":"1214","article-title":"The effect of renal failure on hepatic drug clearance","volume":"25","author":"MA Touchette","year":"1991","journal-title":"DICP Ann Pharmacother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1681\/ASN.V122326","article-title":"Downregulation of hepatic cytochrome P450 in chronic renal failure","volume":"12","author":"F Leblond","year":"2001","journal-title":"J Am Soc Nephrol JASN"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","author":"S James","year":"2010","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/eurheartj\/ehl305","article-title":"Platelets and heart failure","volume":"27","author":"I Chung","year":"2006","journal-title":"Eur Heart J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"SD Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"L Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","article-title":"Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study","volume":"125","author":"J-L Reny","year":"2012","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.2012.17312","article-title":"Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy","volume":"308","author":"PA Gurbel","year":"2012","journal-title":"JAMA J Am Med Assoc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"JL Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"DA Morrow","year":"2012","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0121620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T18:53:57Z","timestamp":1651604037000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0121620"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0121620","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}